(unprocessed)
TITLE: AI impact on biopharma valuation stays murky SOURCE: BioXconomy DESCRIPTION: <a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxNUUhZR0Y0SnRyaDk5TDNxTm9RamdlNi1iTVY2M1dOX0FOR2ZCZTE2Q1JWQm8wM2ZzdTNOQmRfSm5ueUtnMTRmOURnODJhUHIzWmZJS1cxaXB2aGlsT3VxN3kycFlkaW9ydXotd0FLVVFkdS05LUlsSll3RE1XUEVMM0R0ODJYNXlOSUxFLXh3?oc=5" target="_blank">AI impact on biopharma valuation stays murky</a> <font color="#6f6f6f">BioXconomy</font>
{
"title": "AI impact on biopharma valuation stays murky",
"url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxNUUhZR0Y0SnRyaDk5TDNxTm9RamdlNi1iTVY2M1dOX0FOR2ZCZTE2Q1JWQm8wM2ZzdTNOQmRfSm5ueUtnMTRmOURnODJhUHIzWmZJS1cxaXB2aGlsT3VxN3kycFlkaW9ydXotd0FLVVFkdS05LUlsSll3RE1XUEVMM0R0ODJYNXlOSUxFLXh3?oc=5",
"source": "BioXconomy",
"published": "2026-07-30T22:29:14+00:00",
"topic": "ai"
}